e-learning
resources
European Respiratory Review
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Animal models of pulmonary emphysema: a stereologist's perspective
Fehrenbach H.
Source:
Eur Respir Rev 2006; 15: 136-147
Journal Issue:
December 2006 - 15 (101)
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fehrenbach H.. Animal models of pulmonary emphysema: a stereologist's perspective. Eur Respir Rev 2006; 15: 136-147
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans
Source: Eur Respir J 2005; 25: 173-180
Year: 2005
The immunomodulatory effect of protein S in pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Dilatation reserve of pulmonary arteries at stages of COPD experimental model
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Stratified medicine: drugs meet genetics
Source: Eur Respir Rev 2013; 22: 53-57
Year: 2013
Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013
Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006
Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Animal models of pulmonary hypertension in COPD
Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Year: 2010
Role of survivin in experimental models of pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Distinct clinical phenotypes of airways disease defined by cluster analysis
Source: Eur Respir J 2009; 34: 812-818
Year: 2009
Elastase-induced emphysema is attenuated by L-carnitine supplementation
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept